LOGO
LOGO

Intraday Alerts

Sanuwave Health Plunges 40% After Cutting Q2 Revenue Guidance

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us

Shares of SANUWAVE Health, Inc. (SNWV) tumbled 40% on Tuesday morning after the company lowered its second-quarter revenue outlook, citing weakness in capital equipment sales for its Ultramist wound care system.

The stock is currently trading at $8.75, down $5.92 or 40.35%, on the Nasdaq. It opened at $9.95 after closing the previous session at $14.67. The stock has traded between $8.58 and $46.58 over the past 52 weeks.

Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial - No Payment Required
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Business News

Looking to Invest in the Best Biotech Stocks? Subscribe to RTT Biotech Investor.
Global Economics Weekly Update - Jun 08-12, 2026

June 12, 2026 17:14 ET
Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.

RELATED NEWS